Company / Book Value per Share
Intellia Therapeutics, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$6.58
FY2025
5-year range
$4.075 / $12.057
FY2021-FY2025
Trend
-29.8%
vs FY2024
Sector context
#113 of 158
Health Care
What the data says
At $6.58, Intellia Therapeutics, Inc.'s book value per share ranks #113 of 158 in the Health Care sector. Book Value per Share has fluctuated over the past 10 years, ranging from $4.075 in FY2021 to $12.057 in FY2023.
Based on SEC 10-K filings.
$6.58 in FY2025 with a 5-year CAGR of -8.9%.
Declined from $12.057 to $6.58 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -2.4%
- 5-Year CAGR
- -8.9%
- 10-Year CAGR
- -
Sector benchmark
#113 of 158 in Health CareTop 72% of 158This company $6.58 Sector average $48.072
▼
-86.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -8.9%, indicating a declining trend.
- In FY2025, book value per share decreased 29.8% year-over-year.
- Ranks #113 out of 158 companies in the Health Care sector.
- Peak book value per share was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.58 | -29.8% |
| FY2024 | $9.376 | -22.2% |
| FY2023 | $12.057 | +70.4% |
| FY2022 | $7.076 | +73.7% |
| FY2021 | $4.075 | -61.2% |
| FY2020 | $10.5 | +58.0% |
| FY2019 | $6.647 | +34.3% |
| FY2018 | $4.951 | -40.7% |
| FY2017 | $8.349 | -11.6% |
| FY2016 | $9.443 | +110.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026